The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels.
One of the factors contributing to the increased risk of developing premature atherosclerosis is low plasma concentrations of high-density lipoprotein (HDL) cholesterol (HDLc). Multiple potential mechanisms account for the cardioprotective effects of HDL and its main protein apolipoprotein A-I (apo A-I). The low plasma concentrations of HDL could be the result of increased fractional clearance and reduced expression of apo A-I. To this end, nutrients play an important role in modulating the fractional clearance rate, as well as the rate of apo A-I gene expression. Because medical nutrition therapy constitutes the cornerstone of management of dyslipidemias, it is essential to understand the mechanisms underlying the changes in HDL level in response to alterations in dietary intake. In this review, we will discuss the effect of select nutrients on serum HDLc and apo A-I levels. Specifically, we will review the literature on the effect of carbohydrates, fatty acids, and ketones, as well as some of the nutrient-related metabolites, such as glucosamine and the prostanoids, on apo A-I gene expression. Because there are multiple mechanisms involved in the regulation of serum HDLc levels, changes in gene transcription do not necessarily correlate with clinical observations on serum levels of HDLc.
Mooradian
Arshag D
AD
Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, 1402 South Grand Boulevard, St. Louis, Missouri 63104, USA. mooradad@slu.edu
Haas
Michael J
MJ
Wong
Norman C W
NC
D000818:Animals; D016632:Apolipoprotein A-I / Q000097:blood* / Q000235:genetics; D002460:Cell Line; D008076:Cholesterol, HDL / Q000097:blood* / Q000235:genetics; D004032:Diet; D004040:Dietary Carbohydrates / Q000008:administration & dosage / Q000494:pharmacology*; D004041:Dietary Fats / Q000008:administration & dosage / Q000494:pharmacology*; D005227:Fatty Acids / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects; D005944:Glucosamine / Q000494:pharmacology; D006801:Humans; D007659:Ketones / Q000494:pharmacology*; D018673:Nutrition Policy; D011453:Prostaglandins / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects
D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D005227:Fatty Acids; D007659:Ketones; D011453:Prostaglandins; D005944:Glucosamine